A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants who were completely removed by surgery as an auxiliary treatment
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 18 do 75 lat
- •Dobrowolna zgoda na uczestnictwo w badaniu
- •Potwierdzony rак płuca (nie małokomórkowy) po operacji chirurgicznej
✗ Disqualifies
- •Mutacja genu EGFR
- •Małokomórkowy rак płuca lub mieszane nowotwory
- •Wcześniejsze leczenie immunoterapią (anty-PD-1, anty-PD-L1/2 lub podobne)
- •Ponad 4 cykle chemioterapii wspomagającej
- •Aktywna poważna infekcja wymagająca antybiotyków w ostatnich 2 tygodniach
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- July 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Union Hospital Tongji Medical College Huazhong University of Science & Technology
Wuhan, China
Trial contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.